Synergistic effects of GFAP with TNFR1 and TNFR2 on conversion to AD dementia and overall survival across the Alzheimer's disease spectrum
Interaction of GFAP with TNFR1 and TNFR2 seems to be clinically relevant for progression to AD dementia and mortality in Aβ+ participants.
Authors
- Miloš D. Ikonomović (ORCID: https://orcid.org/0000-0002-8745-3293)
- Laura Alejandra Ramirez Tirado
- Cristy Matan
- Ann D Cohen
- Oscar L Lopez
- C. Elizabeth Shaaban
- Thomas K Karikari
- Brian J Lopresti
- Victor L Villemagne
Institutions
- Thomas Jefferson University (US)
- University of Pittsburgh (US)
- UPMC Health System (US)
- Alzheimer’s Disease Neuroimaging Initiative (US)
- VA Pittsburgh Healthcare System (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_106860
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00